Browsing: Mortality Risk
Longevity and Mortality Investor’s coverage of bulk purchase annuity transactions. We are a leading source globally for mortality risk analysis, commentary and insights.
Reverse mortgage securitisation activity is set to pick up in the coming years.
Demand for balance sheet solutions from insurers and supply of capital from asset managers provide market with solid fundamentals to maintain recent activity.
The outlook for metastatic melanoma continues to improve, driven by advancements in therapeutic strategies and ongoing research.
Arguably, the US life insurance industry had a strong 2023 from a balance sheet perspective. Asset growth outpaced liability growth, and policy reserves grew as well and the legacy of the Covid-19 pandemic would appear to be diminishing.
Life Risk News Q&A: Cobus Daneel, Chair, Continuous Mortality Investigation Projections Committee, shares what is top of mind in the mortality actuarial world as we look ahead to 2025.
Farsight Partners has finalised an agreement with funds managed by AB CarVal to source and advise on up to $1bn of transactions.
New research suggests that the chances then that the next 100 years or so brings about a similar jump?
It could take decades for the new legislation to have any discernible impact on mortality.
Life Risk News’ latest roundtable digs deep into the current state of ESG as it pertains to the life risk industry.
While ageing is fundamentally a physiological phenomenon, numerous factors significantly influence the rate at which this process occurs. Certain factors can accelerate the ageing process, while some have the potential to decelerate it, influencing the rate of physiological decline.